Newfane Family Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2731 Main St, Newfane, NY 14108 Phone: 716-778-0926 Fax: 716-778-0926 |
News Archive
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).
Recent surveys have shown that the general public's understanding about what our kidneys do and what the risk factors for kidney disease are, is astoundingly poor. In the UK, five leading kidney charities are joining forces in the campaign "Kidney Charities Together," which calls for urgent action to be taken to raise awareness of kidney disease.
You're already 25 and you still live with your parents. You're 26 and you still bring your laundry take home food from your mother.
A new consensus statement published in the September, 2010, issue of The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) finds that the increasing recognition that beta-cell failure occurs much earlier and severely than commonly believed suggests that regular glycemia screening, early identification of patients at metabolic risk and prompt and aggressive intervention deserves greater emphasis.
› Verified 7 days ago